Please assess the completion status of the following clinical trial:

Trial Title: Sugar-replacement Sweeteners, and Blood Sugar Control

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* body mass index (BMI) over 30.~* Homeostasis model assessment of insulin resistance (HOMA-IR) \< or = 2.6~Exclusion Criteria:~* smoking or smoked within last six months~* pregnant or breastfeeding~* have malabsorptive syndromes~* intestinal inflammatory disease~* diabetes~* liver or kidney disease~* fructose intolerance~* consuming more than one can of diet beverage or one spoonful of non-nutritive sweeteners (e.g. sucralose, aspartame, or saccharine) a week.~* taking any medication that might affect metabolism or taste.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- water-sucralose (Type: EXPERIMENTAL): Subjects in this group drank water 10 min before drinking a glucose load on their first oral glucose tolerance test (OGTT) and drank sucralose 10 min before drinking a glucose load on their second OGTT. The two OGTT were separated on average by 1 week (i.e. washout was approximately 1 week).
- sucralose-water (Type: EXPERIMENTAL): Subjects in this group drank sucralose 10 min before drinking a glucose load on their first OGTT and drank water 10 min before drinking a glucose load on their second OGTT. The two OGTT were separated on average by 1 week (i.e. washout was approximately 1 week).

Based on this trial design, predict the completion outcome and termination type (if applicable).